User login
Article Type
Changed
Thu, 12/15/2022 - 18:02
Display Headline
Endocrine therapy in metastatic breast cancer: a closer look at the current clinical practice
Endocrine therapy is a very effective and well tolerated approach in the treatment of hormone receptor positive metastatic breast cancer. Endocrine therapy has shown comparable results to chemotherapy with regard to survival rates, and therefore, it is recommended in the initial treatment of metastatic breast cancer, except in patients with rapidly progressive disease, where chemotherapy is needed. We have several options of endocrine therapy in first and subsequent lines of treatment in premenopausal and postmenopausal women with metastatic breast cancer, and there has been a great progress in the development of newer agents and combinations.
Click on the PDF icon at the top of this introduction to read the full article.
Article PDF
Issue
The Journal of Community and Supportive Oncology - 13(10)
Topics
Page Number
356-361
Legacy Keywords
endocrine therapy, metastatic breast cancer, MBC, premenopausal, postmenopausal, chemotherapy, estrogen receptor-positive, ER-positive, progesterone receptor-positive, PgR-positive, human epidermal growth factor receptor 2, HER2, nonamplified, selective estrogen receptor modulator, SERM, tamoxifen, ovarian suppression, ablation, aromatase inhibitor
Sections
Article PDF
Article PDF
Endocrine therapy is a very effective and well tolerated approach in the treatment of hormone receptor positive metastatic breast cancer. Endocrine therapy has shown comparable results to chemotherapy with regard to survival rates, and therefore, it is recommended in the initial treatment of metastatic breast cancer, except in patients with rapidly progressive disease, where chemotherapy is needed. We have several options of endocrine therapy in first and subsequent lines of treatment in premenopausal and postmenopausal women with metastatic breast cancer, and there has been a great progress in the development of newer agents and combinations.
Click on the PDF icon at the top of this introduction to read the full article.
Endocrine therapy is a very effective and well tolerated approach in the treatment of hormone receptor positive metastatic breast cancer. Endocrine therapy has shown comparable results to chemotherapy with regard to survival rates, and therefore, it is recommended in the initial treatment of metastatic breast cancer, except in patients with rapidly progressive disease, where chemotherapy is needed. We have several options of endocrine therapy in first and subsequent lines of treatment in premenopausal and postmenopausal women with metastatic breast cancer, and there has been a great progress in the development of newer agents and combinations.
Click on the PDF icon at the top of this introduction to read the full article.
Issue
The Journal of Community and Supportive Oncology - 13(10)
Issue
The Journal of Community and Supportive Oncology - 13(10)
Page Number
356-361
Page Number
356-361
Topics
Article Type
Display Headline
Endocrine therapy in metastatic breast cancer: a closer look at the current clinical practice
Display Headline
Endocrine therapy in metastatic breast cancer: a closer look at the current clinical practice
Legacy Keywords
endocrine therapy, metastatic breast cancer, MBC, premenopausal, postmenopausal, chemotherapy, estrogen receptor-positive, ER-positive, progesterone receptor-positive, PgR-positive, human epidermal growth factor receptor 2, HER2, nonamplified, selective estrogen receptor modulator, SERM, tamoxifen, ovarian suppression, ablation, aromatase inhibitor
Legacy Keywords
endocrine therapy, metastatic breast cancer, MBC, premenopausal, postmenopausal, chemotherapy, estrogen receptor-positive, ER-positive, progesterone receptor-positive, PgR-positive, human epidermal growth factor receptor 2, HER2, nonamplified, selective estrogen receptor modulator, SERM, tamoxifen, ovarian suppression, ablation, aromatase inhibitor
Sections
Citation Override
JCSO 2015;13:356-36
Disallow All Ads
Alternative CME
Article PDF Media
Document